Related Experiment Videos
Gemcitabine-induced extensive skin necrosis.
Sara D'epiro1, Monica Salvi, Carlo Mattozzi
1Dipartimento di Dermatologia, Policlinico Umberto I, "Sapienza" Università di Roma, Viale del Policlinico 155, 00160 Roma, Italy ; Dipartimento di Scienze Radiologiche, Oncologiche e Anatomo-Patologiche Policlinico Umberto I, "Sapienza" Università di Roma, Viale del Policlinico 155, 00160 Roma, Italy.
Case Reports in Medicine
|January 11, 2013
Summary
Gemcitabine chemotherapy can cause severe skin necrosis, particularly in patients with pre-existing vascular conditions. This case highlights the importance of monitoring for chemotherapy-induced vascular toxicity in cancer patients.
Area of Science:
- Oncology
- Dermatology
- Vascular Medicine
Background:
- Metastatic pancreatic cancer treatment often involves chemotherapy.
- Gemcitabine is a common chemotherapeutic agent.
- Vascular side effects of chemotherapy, including skin necrosis, are increasingly recognized.
Purpose of the Study:
- To report a case of severe skin necrosis potentially induced by Gemcitabine chemotherapy.
- To discuss the vascular toxicity of Gemcitabine.
- To emphasize the need for caution in patients with risk factors for vascular events.
Main Methods:
- Case report of an 82-year-old woman treated with Gemcitabine for metastatic pancreatic cancer.
- Clinical observation of extensive necrotic ulcerative lesions on lower limbs.
- Exclusion of cardiovascular and autoimmune etiologies for skin lesions.
Main Results:
- The patient developed severe skin necrosis after Gemcitabine chemotherapy.
- A temporal and causal relationship between Gemcitabine infusion and skin necrosis was established.
- No evidence of cardiovascular or autoimmune disease was found.
Conclusions:
- Gemcitabine can cause significant vascular toxicity, including skin necrosis.
- Oncologic patients undergoing Gemcitabine therapy require careful monitoring for vascular side effects.
- Particular vigilance is advised for patients with a history of arterial vascular disease, venous thromboembolism, or collagenoses.
Related Concept Videos
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
01:16Cellular Injury IV: Necrosis
Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:22Burn Injuries
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...